Over the past four decades, antiretroviral therapy has transformed HIV care. A diagnosis that was once frequently fatal can now be managed as a chronic condition. Treatment has extended life expectancy and improved quality of life. It has also enabled millions of people living with HIV to remain healthy and productive. Preventing new infections remains a major challenge. South Africa…
Tag: Injectable PrEP
-
Lenacapavir PrEP Rollout Brings Hope Amid Service Cuts
South Africa has launched lenacapavir, a new injectable form of pre-exposure prophylaxis, or PrEP. The injection provides six months of protection against HIV infection. It is given twice a year. Health experts say the Lenacapavir PrEP Rollout could be a major step forward for HIV prevention. It offers an alternative to oral PrEP, which requires people to take tablets regularly.…
-
Sakeliga’s NHI Legal Battle for Constiutional Justice
Sakeliga’s NHI Legal Battle has garnered attention. The business lobby group Sakeliga has become the latest organisation to mount a legal challenge against South Africa’s contentious National Health Insurance (NHI) Act. They filed papers at the Pretoria High Court to have it declared unconstitutional and invalid. The focus of Sakeliga’s NHI Legal Battle is to highlight the impracticalities and financial…
-
Lenacapavir for HIV Prevention in South Africa
South Africa is taking a giant step in its fight against HIV. The Department of Health announced plans to make a new, twice-yearly anti-HIV injection available in public clinics. The drug, lenacapavir, represents a potential turning point for HIV prevention. It could significantly curb new infections across the nation. Introducing lenacapavir for HIV prevention could change the landscape of health…